Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia

被引:18
作者
Macri, Antonio [1 ]
Fortugno, Anna [1 ]
Saladino, Edoardo [1 ]
机构
[1] Univ Messina, Dept Human Pathol, Gen Surg Unit, I-98125 Messina, Italy
关键词
Hyperthermic intraperitoneal chemotherapy; Peritoneal surface malignancies; Peritoneal carcinomatosis; Cytoreductive surgery; Loco-regional treatments;
D O I
10.4251/wjgo.v3.i12.169
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The evolution of loco-regional treatments has occurred in the last two decades and has deeply changed the natural history of primitive and secondary peritoneal surface malignancies. Several phase II-II studies have proved the effectiveness of the combination of cytoreductive surgery with peritoneal chemohyperthermia. Cytoreductive surgery allows the reduction of the neoplastic mass and increases tumoral chemosensitivity. The development of chemohyperthermia finds its origins in the necessity to exceed the limits of intraperitoneal chemotherapy performed in normothermia. It permits a continuous high concentration gradient of chemotherapeutic drugs between the peritoneal cavity and the plasma compartment to and a more uniform distribution throughout the abdominal cavity compared to systemic administration. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 37 条
[1]
ULTRASTRUCTURAL-CHANGES INDUCED BY HYPERTHERMIA IN CHINESE-HAMSTER V79 FIBROBLASTS [J].
ARANCIA, G ;
TROVALUSCI, PC ;
MARIUTTI, G ;
MONDOVI, B .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1989, 5 (03) :341-350
[2]
Pseudomyxoma peritonei [J].
Bevan, Katharine E. ;
Mohamed, Faheez ;
Moran, Brendan J. .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 2 (01) :44-50
[3]
Collins JM, 1990, CANC CHEMOTHERAPY PR
[4]
Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options [J].
Davies, Janine Marie ;
O'Neil, Bert .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (07) :913-919
[5]
Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis [J].
De Simone, M ;
Barone, R ;
Vaira, M ;
Aghemo, B ;
Mioli, P ;
Franco, C ;
Scuderi, S ;
Costamagna, D ;
Dei Poli, M .
JOURNAL OF SURGICAL ONCOLOGY, 2003, 82 (02) :138-140
[6]
Deraco M, 2003, J EXP CLIN CANC RES, V22, P41
[7]
Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer [J].
Deraco, M. ;
Baratti, D. ;
Laterza, B. ;
Balestra, M. R. ;
Mingrone, E. ;
Macri, Antonio ;
Virzi, S. ;
Puccio, F. ;
Ravenda, P. S. ;
Kusamura, S. .
EJSO, 2011, 37 (01) :4-9
[8]
Deraco M, 1999, TUMORI, V85, P1
[9]
Deraco Marcello, 2003, Surg Oncol Clin N Am, V12, P561, DOI 10.1016/S1055-3207(03)00027-9
[10]
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial [J].
Deraco, Marcello ;
Kusamura, Shigeki ;
Virzi, Salvatore ;
Puccio, Francesco ;
Macri, Antonio ;
Famulari, Ciro ;
Solazzo, Massimiliano ;
Bonomi, Serena ;
Iusco, Domenico Rosario ;
Baratti, Dario .
GYNECOLOGIC ONCOLOGY, 2011, 122 (02) :215-220